Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sveikatal is a Lithuanian biotechnology company focused on the development and commercialization of science-based nutritional supplements and therapeutic solutions. The company specializes in metabolic health, particularly targeting conditions such as type 2 diabetes and obesity through innovative formulations. Their flagship research involves the use of specific bioactive compounds and peptides derived from natural sources to modulate metabolic pathways. Sveikatal aims to bridge the gap between traditional nutrition and pharmaceutical intervention by providing clinically validated products that support glucose regulation and overall metabolic wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sveikatal.